The crystal structure of the catalytic domain of tau tubulin kinase 2 in complex with a small-molecule inhibitor.

Acta Crystallographica. Section F, Structural Biology Communications
Douglas J MarcotteJayanth V Chodaparambil

Abstract

Tau proteins play an important role in the proper assembly and function of neurons. Hyperphosphorylation of tau by kinases such as tau tubulin kinase (TTBK) has been hypothesized to cause the aggregation of tau and the formation of neurofibrillary tangles (NFTs) that lead to the destabilization of microtubules, thereby contributing to neurodegenerative diseases such as Alzheimer's disease (AD). There are two TTBK isoforms with highly homologous catalytic sites but with distinct tissue distributions, tau phosphorylation patterns and loss-of-function effects. Inhibition of TTBK1 reduces the levels of NFT formation involved in neurodegenerative diseases such as AD, whereas inhibition of TTBK2 may lead to the movement disorder spinocerebellar ataxia type 11 (SCA11). Hence, it is critical to obtain isoform-selective inhibitors. Structure-based drug design (SBDD) has been used to design highly potent and exquisitely selective inhibitors. While structures of TTBK1 have been reported in the literature, TTBK2 has evaded structural characterization. Here, the first crystal structure of the TTBK2 kinase domain is described. Furthermore, the crystal structure of human TTBK2 in complex with a small-molecule inhibitor has successfully been d...Continue Reading

References

Sep 18, 1995·FEBS Letters·M TakahashiA Omori
Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·A C AlonsoK Iqbal
Jul 11, 2007·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Michiko Kitano-TakahashiToshiyuki Kohno
Aug 1, 2007·Journal of Applied Crystallography·Airlie J McCoyRandy J Read
Jun 23, 2009·Journal of Alzheimer's Disease : JAD·Thibaud LebouvierPascal Derkinderen
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Wolfgang Kabsch
Apr 13, 2010·Acta Crystallographica. Section D, Biological Crystallography·P EmsleyK Cowtan
Dec 15, 2010·The International Journal of Biochemistry & Cell Biology·Jit Kong Cheong, David M Virshup
Apr 5, 2011·Acta Crystallographica. Section D, Biological Crystallography·Philip R Evans
Jan 22, 2013·ACS Medicinal Chemistry Letters·Vassilios MyrianthopoulosAlexios-Leandros Skaltsounis
Mar 19, 2014·Acta Crystallographica. Section F, Structural Biology Communications·Susan E KieferSteven Sheriff
May 9, 2014·Frontiers in Molecular Neuroscience·Seiko Ikezu, Tsuneya Ikezu
Jan 20, 2018·European Journal of Medicinal Chemistry·Frank LoveringChristoph W Zapf
Oct 8, 2019·Acta Crystallographica. Section D, Structural Biology·Dorothee LiebschnerPaul D Adams

❮ Previous
Next ❯

Citations

May 5, 2021·Journal of Medicinal Chemistry·Tamara HalkinaFelix Gonzalez-Lopez de Turiso

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.